60 Degrees Pharmaceuticals Inc. (SXTP)
NASDAQ · Healthcare
60 Degrees Pharmaceuticals Inc. Gross Profit 2020–2025
60 Degrees Pharmaceuticals Inc. annual/quarterly gross profit history and growth rate from 2020 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- 60 Degrees Pharmaceuticals Inc. gross profit for the quarter ending March 31, 2026 was 76377, a 15.40% decrease year-over-year.
- 60 Degrees Pharmaceuticals Inc. gross profit for the twelve months ending March 31, 2026 was 209873.
- 60 Degrees Pharmaceuticals Inc. annual gross profit for 2025 was 223776, a 0.43% increase from 2024.
- 60 Degrees Pharmaceuticals Inc. annual gross profit for 2024 was 222809, a 200.83% decrease from 2023.
- 60 Degrees Pharmaceuticals Inc. annual gross profit for 2023 was -220977, a 5.65% increase from 2022.
- 60 Degrees Pharmaceuticals Inc. annual gross profit for 2022 was -209162.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
60 Degrees Pharmaceuticals Inc. Gross Profit — FAQ
60 Degrees Pharmaceuticals Inc. (SXTP) gross profit over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is 60 Degrees Pharmaceuticals Inc.'s gross profit?
60 Degrees Pharmaceuticals Inc. (SXTP) reported gross profit of $223,776 for fiscal 2025.
Where can I see SXTP's gross profit history?
The chart and table above show 60 Degrees Pharmaceuticals Inc.'s gross profit by year and by quarter, including the growth rate.